Consensus statement on the management of invasive candidiasis in Intensive Care Units in the Asia-Pacific Region

International Journal of Antimicrobial Agents

Volumn 34, Issue 3, 2009, Pages 205-209

  Hsueh, Po Ren ^a   Graybill, John Richard ^b   Playford, E Geoffrey ^c   Watcharananan, Siriorn Paritpokee ^d   Oh, Myoung Don ^e   Ja'alam, Kamarudin ^f   Huang, Shunwei ^g   Nangia, Vivek ^h   Kurup, Asok ⁱ   Padiglione, Alexander Angelo ^j  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d MAHIDOL UNIVERSITY   (Thailand)

^e Seoul National University College of Medicine   (South Korea)

^f SCHOOL OF HEALTH SCIENCES   (Malaysia)

^g SUN YAT SEN UNIVERSITY   (China)

^h Batra Hospital India   (India)

ⁱ SINGAPORE GENERAL HOSPITAL   (Singapore)

^j MONASH MEDICAL CENTRE   (Australia)

more..

Author keywords

Asia Pacific; Consensus; Intensive Care Unit; Invasive candidiasis

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; ANTIBIOTIC AGENT; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; MICAFUNGIN; PLACEBO; TRIAZOLE; VORICONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CLINICAL FEATURE; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; DRUG EFFICACY; EARLY DIAGNOSIS; EARLY INTERVENTION; FUNGAL COLONIZATION; FUNGUS ISOLATION; GEOGRAPHIC DISTRIBUTION; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; INTENSIVE CARE UNIT; INVASIVE CANDIDIASIS; MORTALITY; OUTCOME ASSESSMENT; POSTOPERATIVE INFECTION; PREOPERATIVE TREATMENT; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; THERAPY DELAY; TREATMENT DURATION;

EID: 67650759720     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.03.014     Document Type: Note

References (38)

1. Wisplinghoff H., Bischoff T., Tallent S.M., Seifert H., Wenzel R.P., and Edmond M.B. Nosocomial bloodstream infections in US hospitals: analysis of 24 179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39 (2004) 309-317
2. Hsueh P.R., Chen M.L., Sun C.C., Chen W.H., Pan H.J., Yang L.S., et al. Antimicrobial drug resistance in pathogens causing nosocomial infections at a university hospital in Taiwan 1981-1999. Emerg Infect Dis 8 (2002) 63-68
3. Wu C.J., Lee H.C., Lee N.Y., Ko N.Y., Wang L.R., and Ko W.C. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan 1996-2003. J Microbiol Immunol Infect 39 (2006) 135-143
4. Frank M., Gur E., Givon-Lavi N., Peled N., Dagan R., and Leibovitz E. Nosocomial bloodstream infections in children and adolescents in southern Israel: a 10-year prospective study (1992-2001). Scand J Infect Dis 37 (2005) 177-183
5. Ronveaux O., Jans B., Suetens C., and Carsauw H. Epidemiology of nosocomial bloodstream infections in Belgium 1992-1996. Eur J Clin Microbiol Infect Dis 17 (1998) 695-700
6. Hsueh P.R., Teng L.J., Yang P.C., Ho S.W., and Luh K.T. Emergence of nosocomial candidemia at a teaching hospital in Taiwan from 1981 to 2000: increased susceptibility of Candida species to fluconazole. Microb Drug Resist 8 (2002) 311-319
7. Pfaller M.A., and Diekema D.J. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20 (2007) 133-163
8. Kossoff E.H., Buescher E.S., and Karlowicz M.G. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J 17 (1998) 504-508
9. Voss A., le Noble J.L., Verduyn Lunel F.M., Foudraine N.A., and Meis J.F. Candidemia in intensive care unit patients: risk factors for mortality. Infection 25 (1997) 8-11
10. Marchetti O., Bille J., Fluckiger U., Eggiman P., Ruef C., Garbino J., et al. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends 1991-2000. Clin Infect Dis 38 (2004) 311-320
11. Blot S.I., Vandewoude K.H., Hoste E.A., and Colardyn F.A. Effects of nosocomial candidemia on outcomes of critically ill patients. Am J Med 113 (2002) 480-485
12. Diekema D.J., Messer S.A., Brueggemann A.B., Coffman S.L., Doern G.V., Herwaldt L.A., et al. Epidemiology of candidemia: 3-year results from the Emerging Infections and the Epidemiology of Iowa Organisms study. J Clin Microbiol 40 (2002) 1298-1302
13. Rangel-Frausto M.S., Wiblin T., Blumberg H.M., Saiman L., Patterson J., Rinaldi M., et al. National Epidemiology of Mycoses Survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 29 (1999) 253-258
14. Nakamura T., and Takahashi H. Epidemiological study of Candida infections in blood: susceptibilities of Candida spp. to antifungal agents, and clinical features associated with the candidemia. J Infect Chemother 12 (2006) 132-138
15. Takakura S., Fujihara N., Saito T., Kudo T., Iinuma Y., and Ichiyama S. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin. J Antimicrob Chemother 53 (2004) 283-289
16. Chow J.K., Golan Y., Ruthazer R., Karchmer A.W., Carmeli Y., Lichtenberg D.A., et al. Risk factors for albicans and non-albicans candidemia in the intensive care unit. Crit Care Med 36 (2008) 1993-1998
17. Pfaller M.A., Messer S.A., Boyken L., Tendolkar S., Hollis R.J., and Diekema D.J. Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002. J Clin Microbiol 42 (2004) 3142-3146
18. Pfaller M.A., Diekema D.J., Rinaldi M.G., Barnes R., Hu B., Veselov A.V., et al. Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing. J Clin Microbiol 43 (2005) 5848-5859
19. Ruan SY, Huang YT, Chu CC, Yu CJ, Hsueh PR. Candida glabrata fungaemia in a tertiary centre in Taiwan: antifungal susceptibility and outcomes. Int J Antimicrob Agents 2009 Apr 8. [Epub ahead of print] PMID: 19361960.
20. Yang C.W., Barkham T.M., Chan F.Y., and Wang Y. Prevalence of Candida species, including Candida dubliniensis, in Singapore. J Clin Microbiol 41 (2003) 472-474
21. Ruan S.Y., Lee L.N., Jerng J.S., Yu C.J., and Hsueh P.R. Candida glabrata fungaemia in intensive care units. Clin Microbiol Infect 14 (2008) 136-140
22. Morrell M., Fraser V.J., and Kollef M.H. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49 (2005) 3640-3645
23. Garey K.W., Rege M., Pai M.P., Mingo D.E., Suda K.J., Turpin R.S., et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis 43 (2006) 25-31
24. Eggimann P., Francioli P., Bille J., Schneider R., Wu M.M., Chapuis G., et al. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 27 (1999) 1066-1072
25. Pelz R.K., Hendrix C.W., Swoboda S.M., Diener-West M., Merz W.G., et al. Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 233 (2001) 542-548
26. Garbino J., Lew D.P., Romand J.A., Hugonnet S., Auckenthaler R., and Pittet D. Results of Candida prophylaxis in ICU patients. Intensive Care Med 28 (2002) 1708-1717
27. Playford E.G., Webster A.C., Sorrell T.C., and Craig J.C. Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials. J Antimicrob Chemother 52 (2006) 628-638
28. Eggimann P., Garbino J., and Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 3 (2003) 685-702
29. Ostrosky-Zeichner L., and Pappas P.G. Invasive candidiasis in the intensive care unit. Crit Care Med 34 (2006) 857-863
30. Ostrosky-Zeichner L., Sable C., Sobel J., Alexander B.D., Donowitz G., Kan V., et al. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 26 (2007) 271-276
31. Pittet D., Monod M., Suter P.M., Frenk E., and Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220 (1994) 751-758
32. León C., Ruiz-Santana S., Saavedra P., Almirante B., Nolla-Salas J., Alvarez-Lerma F., et al. A bedside scoring system ('Candida score') for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 34 (2006) 730-737
33. Piarroux R., Grenouillet F., Balvay P., Tran V., Blasco G., Millon L., et al. Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med 32 (2004) 2443-2449
34. Takesue Y., Kakehashi M., Ohge H., Imamura Y., Murakami Y., Sasaki M., et al. Combined assessment of β-d-glucan and degree of Candida colonization before starting empiric therapy for candidiasis in surgical patients. World J Surg 28 (2004) 625-630
35. Schuster M.G., Edwards Jr. J.E., Sobel J.D., Darouiche R.O., Karchmer A.W., Hadley S., et al. Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. Ann Intern Med 149 (2008) 83-90
36. Golan Y., Wolf M., Pauker S., Wong J., and Hadley S. Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis. Ann Intern Med 143 (2005) 857-869
37. Pappas P.G., Rex J.H., Sobel J.D., Filler S.G., Dismukes W.E., Walsh T.J., et al. Guidelines for the treatment of candidiasis. Clin Infect Dis 38 (2004) 161-189
38. Pappas P.G., Kauffman C.A., Andes D., Benjamin D.K., Calandra T.F., Edwards J.E., et al. Guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48 (2009) 503-535